
FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
WASHINGTON, D.C. — The U.S. Food and Drug Administration this week issued guidance for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential …
Read More